Systematic review / meta-analysis / 2022
Ginkgo biloba may have little to no effect on tinnitus symptom severity compared to placebo, though the evidence is very uncertain.
A Cochrane systematic review analyzed 12 parallel-group RCTs (1,915 participants) evaluating Ginkgo biloba for subjective tinnitus. Very low-certainty evidence from two pooled studies showed Ginkgo biloba may have little to no effect on tinnitus symptom severity compared to placebo at 3 to 6 months (MD -1.35, 95% CI -8.26 to 5.55; 85 participants). No serious adverse effects were reported across 4 studies (1,154 participants; low-certainty), and other adverse effects did not differ significantly from placebo (RR 0.91, 95% CI 0.52 to 1.60; 4 studies; 1,175 participants). Overall evidence was limited by high or unclear risk of bias, small sample sizes, and outcome heterogeneity.
- Study type
- Systematic review and meta-analysis of RCTs
- Who was studied
- 1,915 adults and children with acute or chronic subjective tinnitus across 12 RCTs
- What was measured
- Tinnitus symptom severity, serious adverse effects (bleeding, seizures), loudness, quality of life, and other adverse effects
THE PAPER
Ginkgo biloba for tinnitus.
Sereda M, Xia J, Scutt P, Hilton MP, El Refaie A, Hoare DJ. Cochrane Database Syst Rev, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.